换一批
换一批A pilot study of epratuzumab and rituximab in combination with cyclophosphamide, doxorubicin, vincristine, and prednisone chemotherapy in patients with previously untreated, diffuse large B-cell lymphoma.
作者：
主题词
成年人(Adult);老年人(Aged);抗体, 单克隆(Antibodies, Monoclonal);抗体, 单克隆, 鼠源性(Antibodies, Monoclonal, Murine-Derived);抗肿瘤联合化疗方案(Antineoplastic Combined Chemotherapy Protocols);环磷酰胺(Cyclophosphamide);无病生存(Disease-Free Survival);多柔比星(Doxorubicin);女(雌)性(Female);人类(Humans);淋巴瘤, B细胞(Lymphoma, B-Cell);淋巴瘤, 大B细胞, 弥漫性(Lymphoma, Large B-Cell, Diffuse);男(雄)性(Male);中年人(Middle Aged);试点项目(Pilot Projects);泼尼松(Prednisone);治疗结果(Treatment Outcome);长春新碱(Vincristine)
DOI
10.1002/cncr.22342
PMID
17099879
发布时间
2017-11-16
- 浏览18
Cancer
2826-32页
相似文献
- 中文期刊
- 外文期刊
- 学位论文
- 会议论文
